UK markets closed

ACADIA Pharmaceuticals Inc. (ACAD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
15.76+0.42 (+2.74%)
At close: 04:00PM EST
15.76 0.00 (0.00%)
After hours: 04:56PM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts2172120
Avg. Estimate-0.25-0.28-1.32-0.78
Low estimate-0.3-0.4-1.39-1.46
High estimate-0.15-0.21-1.13-0.3
Year ago EPS-0.27-0.7-1.05-1.32
Revenue estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts1842120
Avg. Estimate134.39M121.7M515.31M585.33M
Low estimate129.7M118M510.4M538.5M
High estimate139M125M519.7M638.67M
Year ago sales130.76M115.47M484.14M515.31M
Sales growth (year/est)2.80%5.40%6.40%13.60%
Earnings history30/12/202130/03/202229/06/202229/09/2022
Est. EPS-0.24-0.6-0.25-0.19
Actual EPS-0.27-0.7-0.21-0.17
Difference-0.03-0.10.040.02
Surprise %-12.50%-16.70%16.00%10.50%
EPS trendCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Current estimate-0.25-0.28-1.32-0.78
7 days ago-0.25-0.28-1.32-0.78
30 days ago-0.19-0.29-1.28-0.69
60 days ago-0.2-0.28-1.28-0.54
90 days ago-0.21-0.28-1.29-0.58
EPS revisionsCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days2121
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesACADIndustrySector(s)S&P 500
Current qtr.7.40%N/AN/AN/A
Next qtr.60.00%N/AN/AN/A
Current year-25.70%N/AN/AN/A
Next year40.90%N/AN/AN/A
Next 5 years (per annum)25.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A